CXCL12 and cancer: Patients with positive CXCL12 expression in residual survival cancer cells displayed a positive association with worse FFR in univariate and multivariate Cox proportional hazard regression analysis (p = 0.005 and p = 0.031, respectively) (Table 2 and Table 3).